首站-论文投稿智能助手
典型文献
Inhibition of drug-metabolizing enzymes by Jingyin granules:implications of herb-drug interactions in antiviral therapy
文献摘要:
Jingyin granules,a marketed antiviral herbal medicine,have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019(COVID-19)in China.To fight viral diseases in a more efficient way,Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents,including antiviral drugs,anti-inflammatory drugs,and other Western medicines.However,it is unclear whether Jingyin granules modulate the pharmacokinetics of Western drugs or trigger clinically significant herb-drug interactions.This study aims to assess the inhibitory potency of the herbal extract of Jingyin granules(HEJG)against human drug-metabolizing enzymes and to clarify whether HEJG can modulate the pharmacokinetic profiles of Western drug(s)in vivo.The results clearly demonstrated that HEJG dose-dependently inhibited human CES1 A,CES2A,CYPs1 A,2A6,2C8,2C9,2D6,and 2E1;this herbal medicine also time-and NADPH-dependently inhibited human CYP2C19 and CYP3A.In vivo tests showed that HEJG significantly increased the plasma exposure of lopinavir(a CYP3A-substrate drug)by 2.43-fold and strongly prolonged its half-life by 1.91-fold when HEJG(3g/kg)was co-administered with lopinavir to rats.Further investigation revealed licochalcone A,licochalcone B,licochalcone C and echinatin in Radix Glycyrrhizae,as well as quercetin and kaempferol in Folium Llicis Purpureae,to be time-dependent CYP3A inhibitors.Collectively,our findings reveal that HEJG modulates the pharmacokinetics of CYP substrate-drug(s)by inactivating CYP3A,providing key information for both clinicians and patients to use herb-drug combinations for antiviral therapy in a scientific and reasonable way.
文献关键词:
作者姓名:
Feng Zhang;Wei Liu;Jian Huang;Qi-long Chen;Dan-dan Wang;Li-wei Zou;Yong-fang Zhao;Wei-dong Zhang;Jian-guang Xu;Hong-zhuan Chen;Guang-bo Ge
作者机构:
Institute of Interdisciplinary Integrative Medicine Research,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Liver Diseases,Shuguang Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Pharmacology and Toxicology Division,Shanghai Institute of Food and Drug Control,Shanghai 201203,China;SPH Xing Ling Sci.&Tech.Pharmaceutical Co.,Ltd,Shanghai 201703,China
引用格式:
[1]Feng Zhang;Wei Liu;Jian Huang;Qi-long Chen;Dan-dan Wang;Li-wei Zou;Yong-fang Zhao;Wei-dong Zhang;Jian-guang Xu;Hong-zhuan Chen;Guang-bo Ge-.Inhibition of drug-metabolizing enzymes by Jingyin granules:implications of herb-drug interactions in antiviral therapy)[J].中国药理学报(英文版),2022(04):1072-1081
A类:
Jingyin,HEJG,CES2A,CYPs1,2C8,lopinavir,Llicis,Purpureae
B类:
Inhibition,metabolizing,enzymes,by,granules,implications,interactions,antiviral,therapy,marketed,herbal,have,been,recommended,treating,H1N1,influenza,infection,Coronavirus,China,To,fight,diseases,more,efficient,way,are,frequently,administered,settings,variety,therapeutic,agents,including,drugs,inflammatory,other,medicines,However,unclear,whether,pharmacokinetics,trigger,clinically,This,study,aims,assess,inhibitory,potency,extract,against,human,clarify,profiles,vivo,results,clearly,demonstrated,that,dose,dependently,inhibited,CES1,2A6,2C9,2D6,2E1,this,also,NADPH,CYP2C19,CYP3A,tests,showed,significantly,increased,plasma,exposure,substrate,fold,strongly,prolonged,its,half,life,when,3g,was,rats,Further,investigation,revealed,licochalcone,echinatin,Radix,Glycyrrhizae,well,quercetin,kaempferol,Folium,inhibitors,Collectively,our,findings,modulates,inactivating,providing,key,information,both,clinicians,patients,use,combinations,scientific,reasonable
AB值:
0.485174
相似文献
Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
Xi Cheng;Wensi Zhao;Mengdi Zhu;Bo Wang;Xuege Wang;Xiaoyun Yang;Yuqi Huang;Minjia Tan;Jing Li-Department of Bioinformatics and Biostatistics,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;The Chemical Proteomics Center and State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Key Laboratory of Tissue Microenvironment and Tumor,Shanghai Institute of Nutrition and Health,Shanghai Institutes for Biological Sciences,University of Chinese Academy of Sciences,Chinese Academy of Sciences(CAS),Shanghai 200031,China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
Shaojun Zhang;Wenze Huang;Lili Ren;Xiaohui Ju;Mingli Gong;Jian Rao;Lei Sun;Pan Li;Qiang Ding;Jianwei Wang;Qiangfeng Cliff Zhang-MOE Key Laboratory of Bioinformatics,Beijing Advanced Innovation Center for Structural Biology & Frontier Research Center for Biological Structure,Center for Synthetic and Systems Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory,Institute of Pathogen Biology,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China;Key Laboratory of Respiratory Disease Pathogenomics,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Center for infectious Disease Research,School of Medicine,Tsinghua University,Beijing,China
Structures of the endogenous peptide-and selective non-peptide agonist-bound SSTR2 signaling complexes
Li-Nan Chen;Wei-Wei Wang;Ying-Jun Dong;Dan-Dan Shen;Jia Guo;Xuefei Yu;Jiao Qin;Su-Yu Ji;Huibing Zhang;Qingya Shen;Qiaojun He;Bo Yang;Yan Zhang;Qinglin Li;Chunyou Mao-Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University,School of Medicine,Hangzhou,Zhejiang,China;Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Center for Structural Pharmacology and Therapeutics Development,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang,China;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;MOE Frontier Science Center for Brain Research and Brain-Machine Integration,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases,Hangzhou,Zhejiang,China
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yang Yi;Meng Zhang;Heng Xue;Rong Yu;Yang-Oujie Bao;Yi Kuang;Yue Chai;Wen Ma;Jing Wang;Xiaomeng Shi;Wenzhe Li;Wei Hong;Junhua Li;Elishiba Muturi;Hongping Wei;Joachim Wlodarz;Szczepan Roszak;Xue Qiao;Hang Yang;Min Ye-State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;CAS Key Laboratory of Special Pathogens and Biosafety,Center for Biosafety Mega-Science,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan 430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Faculty of Science and Technology,University of Silesia,Katowice 40-007,Poland;Department of Physical and Quantum Chemistry,Faculty of Chemistry,Wroclaw University of Science and Technology,Wroclaw 50-370,Poland
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。